Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
BioRem Inc. (BRM.V)
Puslinch, ON, CA
BioRem Inc. is a clean technology engineering firm specializing in the development, manufacturing, and global distribution of environmental air purification systems. These systems are engineered to combat a range of airborne contaminants, including foul smells, volatile organic compounds (VOCs), and hazardous air pollutants (HAPs). Their comprehensive product line features biofilters for treating odors, hydrogen sulfide (H2S), VOCs, and HAPs, alongside biotrickling filters specifically designed for high concentrations of H2S or water-soluble VOCs. The company also supplies advanced multi-stage systems for odor removal in municipal and urban wastewater treatment facilities, biogas desulfurization systems, dry scrubber adsorption systems, and solutions for cannabis odor control. Complementing its product offerings, BioRem provides essential services such as biological process testing, media sampling and analysis, system reviews and inspections, and the provision of replacement media and spare parts. With operations spanning Canada, the United States, China, and other international regions, BioRem Inc. was founded in 1990 and is based in Puslinch, Canada.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.85% | +2.61% | +37.74% | +31.11% | +58.74% | +31.11% | +68.57% | +247.06% | +543.64% | +1,211.11% | +2.61% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 1 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Industrial - Pollution & Treatment Controls: +8.0%+13.2% ★ Q1'26: +44.1% (vs Q1'25)
-
EPS growth Industrial - Pollution & Treatment Controls: +15.8%+62.5% ★ Q1'26: +450.0% (vs Q1'25)
-
FCF margin FCF growth · Industrial - Pollution & Treatment Controls: +35.7%+15.7% ★ Q1'26: -20.5% (vs Q1'25)
-
EBIT margin Industrial - Pollution & Treatment Controls: +10.2%+15.5% ★ Q1'26: +2.7% (vs Q1'25)
-
ROIC Industrial - Pollution & Treatment Controls: +6.6%+80.0% ★ Q1'26: +6.9% (vs Q1'25)
-
Share dilution Industrial - Pollution & Treatment Controls: 0.0%-0.4% ★ Q1'26: -1.5% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Industrial - Pollution & Treatment Controls: -0.39×0.40× ★ Q1'26: 2.40× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|
| Revenue |
37.42M
est: 36.90M (+1.4%)
|
42.36M
est: 38.90M (+8.9%)
|
47.50M
47.50M – 47.50M
+22.1% YoY
|
| EBITDA |
4.82M
est: 4.76M (+1.2%)
|
7.05M
est: 5.02M (+40.4%)
|
6.13M
6.13M – 6.13M
+22.1% YoY
|
| EBIT |
4.34M
est: 4.28M (+1.5%)
|
6.57M
est: 4.51M (+45.7%)
|
5.51M
5.51M – 5.51M
+22.1% YoY
|
| Net Income |
3.04M
est: 3.54M (-14.1%)
|
4.82M
est: 3.73M (+29.2%)
|
5.59M
5.59M – 5.59M
+50.0% YoY
|
| SGA |
5.62M
est: 5.95M (-5.6%)
|
5.97M
est: 6.27M (-4.9%)
|
7.66M
7.66M – 7.66M
+22.1% YoY
|
| EPS |
0.19
est: 0.19 (+0.0%)
|
0.30
est: 0.20 (+50.0%)
|
0.30
0.30 – 0.30
+50.0% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-15 | A | 4/5 | 4/5 | 5/5 | 5/5 | 3/5 | 4/5 | 2/5 |
| 2026-05-14 | A | 4/5 | 4/5 | 5/5 | 5/5 | 3/5 | 4/5 | 2/5 |
| 2026-05-13 | A | 4/5 | 4/5 | 5/5 | 5/5 | 3/5 | 4/5 | 2/5 |
| 2026-05-12 | A | 4/5 | 4/5 | 5/5 | 5/5 | 3/5 | 4/5 | 2/5 |
| 2026-05-11 | A+ | 4/5 | 5/5 | 5/5 | 5/5 | 3/5 | 4/5 | 2/5 |
| 2026-05-08 | A+ | 4/5 | 5/5 | 5/5 | 5/5 | 3/5 | 4/5 | 2/5 |
| 2026-05-07 | A+ | 4/5 | 5/5 | 5/5 | 5/5 | 3/5 | 4/5 | 2/5 |
| 2026-05-06 | A+ | 4/5 | 5/5 | 5/5 | 5/5 | 3/5 | 4/5 | 2/5 |
| 2026-05-05 | A+ | 4/5 | 5/5 | 5/5 | 5/5 | 3/5 | 4/5 | 2/5 |
| 2026-05-04 | A+ | 4/5 | 5/5 | 5/5 | 5/5 | 3/5 | 4/5 | 2/5 |
| 2026-05-01 | A+ | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 4/5 | 3/5 |
| 2026-04-30 | A+ | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 4/5 | 3/5 |
| 2026-04-29 | A | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 4/5 | 2/5 |
| 2026-04-28 | A | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 4/5 | 2/5 |
| 2026-04-27 | A | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 4/5 | 2/5 |
| 2026-04-24 | A | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 4/5 | 2/5 |
| 2026-04-23 | A | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 4/5 | 2/5 |
| 2026-04-22 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 2/5 | 3/5 | 2/5 |
| 2026-04-21 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 2/5 | 3/5 | 2/5 |
| 2026-04-20 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 2/5 | 3/5 | 2/5 |
| 2026-04-17 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 2/5 | 3/5 | 2/5 |
| 2026-04-16 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 2/5 | 3/5 | 2/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Derek S. Webb | Chief Executive Officer, President & Director | 487.3K | male |
| Douglas Newman | Chief Financial Officer & Secretary | 277.7K | male |
| Dan Costello | Director of Operations | — | male |
| Mark Smit | Director of Technical Services | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for BRM.V
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
